Fig. 7 | Scientific Reports

Fig. 7

From: Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment

Fig. 7

Multiplexing the Lumit Human IL-1β Immunoassay with the Caspase-Glo 1 Inflammasome Assay. MDA-MB-231 cells were transfected with NLRP3 siRNA for 72 h followed by incubation with 100 nM PTX for an additional 24 h. Statistical significance: “*” symbol was used for statistical comparisons between the levels of caspase-1 secreted in each experimental condition; “#” symbol was used for statistical comparisons between the levels of IL-1β secreted in each experimental condition; * p < 0.05 and #### p < 0.0001 (n = 3, biological replicates).

Back to article page